Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase

被引:101
作者
Wang, SH [1 ]
DeGroff, VL [1 ]
Clinton, SK [1 ]
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Internal Med, Div Hematol & Oncol, Columbus, OH 43210 USA
关键词
IGF-I; tomato; soy; polyphenols; prostate;
D O I
10.1093/jn/133.7.2367
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
We examined the ability of polyphenols from tomatoes and soy (genistein, quercetin, kaempferol, biochanin A, daidzein and rutin) to modulate insulin-like growth factor-I (IGF-I)-induced in vitro proliferation and apoptotic resistance in the AT6.3 rat prostate cancer cell line. IGF-I at 50 mug/L in serum-free medium produced maximum proliferation and minimized apoptosis. Polyphenols exhibited different abilities to modulate IGF-I-induced proliferation, cell cycle progression (flow cytometry) and apoptosis (Annexin V/propidium iodide and terminal deoxynucleotidyltransferase-mediated deoxyuridine 5'-triphosphate nick end labeling). Genistein, quercetin, kaempferol and biochanin A exhibited dose-dependent inhibition of growth with a 50% inhibitory concentration (IC50) between 25 and 40 mumol/L, whereas rutin and daidzein were less potent with an IC50 of >60 mumol/L. Genistein and kaempferol potently induced G(2)/M cell cycle arrest. Genistein, quercetin, kaempferol and biochanin A, but not claidzein and rutin, counteracted the antiapoptotic effects of IGF-I. Human prostate epithelial cells grown in growth factor-supplemented medium were also sensitive to growth inhibition by polyphenols. Genistein, biochanin A, quercetin and kaempferol reduced the insulin receptor substrate-1 (IRS-1) content of AT6.3 cells and prevented the down-regulation of IGF-I receptor beta in response to IGF-I binding. IGF-I-stimulated proliferation was dependent on activation of mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK)l and phosphatidylinositide 3-kinase pathways. Western blotting demonstrated that ERK1/2 was constitutively phosphorylated in AT6.3 cells with no change in response to IGF-I, whereas IRS-1 and AKT were rapidly and sensitively phosphorylated after IGF-I stimulation. Several polyphenols suppressed phosphorylation of AKT and ERK1/2, and more potently inhibited IRS-1 tyrosyl phosphorylation after IGF-I exposure. In summary, polyphenols from soy and tomato products may counteract the ability of IGF-I to stimulate proliferation and prevent apoptosis via inhibition of multiple intracellular signaling pathways involving tyrosine kinase activity.
引用
收藏
页码:2367 / 2376
页数:10
相关论文
共 67 条
[1]   Structure and function of the type 1 insulin-like growth factor receptor [J].
Adams, TE ;
Epa, VC ;
Garrett, TPJ ;
Ward, CW .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) :1050-1093
[2]   AUTOCRINE REGULATION OF CELL-PROLIFERATION BY THE INSULIN-LIKE GROWTH-FACTOR (IGF) AND IGF BINDING PROTEIN-3 PROTEASE SYSTEM IN A HUMAN PROSTATE CARCINOMA CELL-LINE (PC-3) [J].
ANGELLOZNICOUD, P ;
BINOUX, M .
ENDOCRINOLOGY, 1995, 136 (12) :5485-5492
[3]  
Balabhadrapathruni S, 2000, ONCOL REP, V7, P3
[4]   Vitamin E succinate inhibits colon cancer liver metastases [J].
Barnett, KT ;
Fokum, FD ;
Malafa, MP .
JOURNAL OF SURGICAL RESEARCH, 2002, 106 (02) :292-298
[5]   The IGF-I receptor in cancer research [J].
Baserga, R .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :1-6
[6]  
Bhatia N, 2001, PROSTATE, V46, P98
[7]  
BOILEAU TW, 2003, IN PRESS J NAT CANC
[8]  
Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
[9]   Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression [J].
Brown, A ;
Jolly, P ;
Wei, HC .
CARCINOGENESIS, 1998, 19 (06) :991-997
[10]   Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1 [J].
Casagrande, F ;
Darbon, JM .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (10) :1205-1215